Clinical Trials Browser

Terminated × OTHER × dactolisib × Clear all

NCT01856101 2019-04-10

BEZ235

Phase 2 Terminated

Carcinoma, Transitional Cell

NCT01508104 2017-08-23

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

Phase 1 Terminated

CNSEndocrineNET

Brain Neoplasms, Glioblastoma, Neoplasms, Neuroendocrine Tumors

NCT01453595 2016-02-29

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Phase 1/2 Terminated

10 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms